News
-
Open Market Consultation Project 3Dx3C (Digital Twin Disruptive Developement For Complex, Congenital Care)
The Open Market Consultation Project 3Dx3C, issued by the Hospital Universitari Vall d'Hebron, closes on March 7th 2025 at 2:00 PM.
-Read more-
-
In silico medicine emerges in Greece
On December 21, 2024, Research Professor Georgios S. Stamatakos, a great pioneer of in silico oncology, delivered a lecture in Sparta (Greece) exploring the emergence, evolution, and clinical potential of in silico medicine.
-Read more-
-
First rules of the Artificial Intelligence Act are now applicable
From 2 February 2025, the first rules under the Artificial Intelligence Act (AI Act) started to apply.
-Read more-
-
EMA Draft Guidance on Mechanistic Models in Model-Informed Drug Development (MIDD)
The European Medicines Agency (EMA) is preparing to release draft guidance on how to assess and report new mechanistic models, aiming to encourage their wider use in model-informed drug development (MIDD).
-Read more-
-
2025/26 VPHi Executive Committee
We are thrilled to present the newly elected Executive Committee that will collaborate with the VPHi BoD and staff members in supporting the full adoption of in silico medicine!
-Read more-
-
My medical choice: From Angelina Jolie to in silico predictive oncology
Angelina Jolieā€™s 2013 op-ed sparked a global conversation on genetic cancer risks. Today, in silico tools like CancerMate advance personalised oncology, improving breast cancer treatment predictions.
-Read more-
